These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 37826990)

  • 1. Harnessing the druggability at orthosteric and allosteric sites of PD-1 for small molecule discovery by an integrated in silico pipeline.
    Mittal L; Tonk RK; Awasthi A; Asthana S
    Comput Biol Chem; 2023 Dec; 107():107965. PubMed ID: 37826990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting cryptic-orthosteric site of PD-L1 for inhibitor identification using structure-guided approach.
    Mittal L; Tonk RK; Awasthi A; Asthana S
    Arch Biochem Biophys; 2021 Nov; 713():109059. PubMed ID: 34673001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virtual screening of a natural compound library at orthosteric and allosteric binding sites of the neurotensin receptor.
    Rejwan Ali M; Sadoqi M; Boutajangout A; Mezei M
    J Biomol Struct Dyn; 2019 Oct; 37(17):4494-4506. PubMed ID: 30479178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Modeling Study of a Receptor-Orthosteric Ligand-Allosteric Modulator Signaling Complex.
    Jiang C; He X; Wang Y; Chen CJ; Othman Y; Hao Y; Yuan J; Xie XQ; Feng Z
    ACS Chem Neurosci; 2023 Feb; 14(3):418-434. PubMed ID: 36692197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative allosteric modulators of cannabinoid receptor 2: protein modeling, binding site identification and molecular dynamics simulations in the presence of an orthosteric agonist.
    Pandey P; Roy KK; Doerksen RJ
    J Biomol Struct Dyn; 2020 Jan; 38(1):32-47. PubMed ID: 30652534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of protein-protein interactions and hot spot region between PD-1 and PD-L1 by fragment molecular orbital method.
    Lim H; Chun J; Jin X; Kim J; Yoon J; No KT
    Sci Rep; 2019 Nov; 9(1):16727. PubMed ID: 31723178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based ligand discovery targeting orthosteric and allosteric pockets of dopamine receptors.
    Lane JR; Chubukov P; Liu W; Canals M; Cherezov V; Abagyan R; Stevens RC; Katritch V
    Mol Pharmacol; 2013 Dec; 84(6):794-807. PubMed ID: 24021214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How Do Modulators Affect the Orthosteric and Allosteric Binding Pockets?
    Chen CJ; Jiang C; Yuan J; Chen M; Cuyler J; Xie XQ; Feng Z
    ACS Chem Neurosci; 2022 Apr; 13(7):959-977. PubMed ID: 35298129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational discovery of small drug-like compounds as potential inhibitors of PD-1/PD-L1 interactions.
    Urban VA; Davidovskii AI; Veresov VG
    J Biomol Struct Dyn; 2023 Jul; 41(11):5345-5361. PubMed ID: 35696453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revealing the Positive Binding Cooperativity Mechanism between the Orthosteric and the Allosteric Antagonists of CCR2 by Metadynamics and Gaussian Accelerated Molecular Dynamics Simulations.
    An X; Bai Q; Bing Z; Liu H; Zhang Q; Liu H; Yao X
    ACS Chem Neurosci; 2020 Feb; 11(4):628-637. PubMed ID: 31968162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PD-1-Targeted Discovery of Peptide Inhibitors by Virtual Screening, Molecular Dynamics Simulation, and Surface Plasmon Resonance.
    Wang Y; Guo H; Feng Z; Wang S; Wang Y; He Q; Li G; Lin W; Xie XQ; Lin Z
    Molecules; 2019 Oct; 24(20):. PubMed ID: 31640203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-talk between allosteric and orthosteric binding sites of γ-amino butyric acid type A receptors (GABA
    Payghan PV; Nath Roy S; Bhattacharyya D; Ghoshal N
    J Biomol Struct Dyn; 2019 Aug; 37(12):3065-3080. PubMed ID: 30608219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of small-molecule PD-1/PD-L1 antagonists through combined virtual screening and experimental validation.
    DiFrancesco M; Hofer J; Aradhya A; Rufinus J; Stoddart J; Finocchiaro S; Mani J; Tevis S; Visconti M; Walawender G; DiFlumeri J; Fattakhova E; Patil SP
    Comput Biol Chem; 2023 Feb; 102():107804. PubMed ID: 36610303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probing the origins of programmed death ligand-1 inhibition by implementing machine learning-assisted sequential virtual screening techniques.
    Kuttappan S; Bhowmik R; Gopi Mohan C
    Mol Divers; 2024 Aug; 28(4):2449-2466. PubMed ID: 37470920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Druggable orthosteric and allosteric hot spots to target protein-protein interactions.
    Ma B; Nussinov R
    Curr Pharm Des; 2014; 20(8):1293-301. PubMed ID: 23713780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of benzo[d]isothiazole derivatives as novel scaffold inhibitors targeting the programmed cell death-1/programmed cell death-ligand 1 (PD-1/PD-L1) interaction through "ring fusion" strategy.
    Gao Y; Wang H; Shen L; Xu H; Deng M; Cheng M; Wang J
    Bioorg Chem; 2022 Jun; 123():105769. PubMed ID: 35405572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based small inhibitors search combined with molecular dynamics driven energies for human programmed cell death-1 (PD-1) protein.
    Waqas M; Halim SA; Alsalman A; Khan A; Elkord E; Al-Harrasi A
    J Biomol Struct Dyn; 2023; 41(24):14771-14785. PubMed ID: 36927289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the structural and energetic basis of PD-1 and monoclonal antibodies bound to PD-L1: A molecular modeling perspective.
    Shi D; Zhou S; Liu X; Zhao C; Liu H; Yao X
    Biochim Biophys Acta Gen Subj; 2018 Mar; 1862(3):576-588. PubMed ID: 29203283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the FDA-Approved Drug Pyrvinium as a Small-Molecule Inhibitor of the PD-1/PD-L1 Interaction.
    Fattakhova E; Hofer J; DiFlumeri J; Cobb M; Dando T; Romisher Z; Wellington J; Oravic M; Radnoff M; Patil SP
    ChemMedChem; 2021 Sep; 16(18):2769-2774. PubMed ID: 34117723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational analysis of PD-L1 dimerization mechanism induced by small molecules and potential dynamical properties.
    Xu X; Luo S; Zhao X; Tang B; Zhang E; Liu J; Duan L
    Int J Biol Macromol; 2024 Apr; 265(Pt 1):130921. PubMed ID: 38492688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.